Canada legalized recreational marijuana five years ago, and a review process is currently underway to evaluate that decision. The review could lead to either tightening or further loosening regulations.
Some are skeptical the review led by government-selected panelists will look at the impacts of legalization through a truly critical lens. Prime Minister Justin Trudeau and his ministers have been strong advocates for legalization.
“I think it should take a close look at regulatory violations and corporate crime in the cannabis industry,” DeVillaer told The Epoch Times via email.
“We haven’t so much replaced a criminal trade as we have moved it,” he said.
While the legislative review, set to culminate in a report early next year, has as part of its focus the “health and cannabis consumption habits of young persons,” retired RCMP drug enforcement officer Larry Comeau says it will likely “gloss over” many problematic aspects of this particular issue, as the government has previously done.
“This review no doubt will gloss over such things as more young people facing mental issues because of pot use, very young children ending up in ERs due to ingesting cannabis edibles, more highway accidents and deaths since legalization, more workplace accidents because of workers smoking up on the job and the general denigration of society,” Comeau told The Epoch Times.
“Too often, advisory boards are packed with representatives of the marijuana industry who aim to weaken safeguards and dismiss valid concerns,” Sabet said via email. “Yet the five members of the Expert Panel have extensive backgrounds in academia and public service, demonstrating their ability to review objectively the wide-ranging consequences of the Cannabis Act.”
Multiple Points of Connection
DeVillaer is a little less confident in expert panels appointed by the government. He questioned the impartiality of a similar panel of experts created ahead of legalization.The Task Force on Cannabis Legalization and Regulation was mandated to seek expert testimony, engage with the public, and conduct a review of scientific studies. The task force was to produce a report to the government that would inform its decision on whether or not to legalize cannabis.
Bennett Jones sought to be the “go-to advisers” for the growing cannabis industry, according to company literature DeVillaer reviewed. One of the firm’s stated business partners was a major up-and-coming Canadian cannabis company called Tweed.
Expert Panel Members
The chair of the current review’s expert panel is former president and CEO of the Pierre Elliott Trudeau Foundation Morris Rosenberg.Rosenberg is a lawyer who has served in many high-level government roles, including as the deputy minister of three different federal departments from 1998 to 2013.
The Epoch Times reached out to the panellists for interviews but did not receive replies as of publication.
Health Canada spokesperson Tammy Jarbeau says the panel will conduct a “credible and inclusive review.”
The panellists were selected “to represent and advocate for Canada’s diversity, with significant public sector experience, expertise in public health and justice, and experience engaging with Indigenous communities and organizations,” Jarbeau said via email.
Industry Push
As the legislative review continues, the government is concurrently looking at rolling back some regulations that the cannabis industry has called “burdensome.” The industry has struggled to remain competitive with the illicit trade. Some of the regulations they seek to roll back relate to packaging and labelling.Yet it is such regulations—along with advertising bans and restrictions on availability—that are most important for minimizing harm, says Centre for Addiction and Mental Health (CAMH) policy analyst Jean-François Crépault.
The submission, provided by two CAMH experts and four scientists from the Canadian Institute for Substance Use Research at the University of Victoria, urges the government to create a standard measure of tetrahydrocannabinol (THC) levels to make potency information clearer to consumers, and to take action to minimize high-potency product sales.
Youth psychiatrist Dafna Kahana is concerned that the proliferation of high-potency products has increased risk to youth, and that normalization of the drug has decreased the awareness of its harms.
“The review of the Cannabis Act that is taking place should continue to prioritize public health,” Kahana said via email. “This is important, as the cannabis industry might have different priorities.”